We are Sorry, This Page doesn't Exist
Sarepta Therapeutics News: SRPT Stock Skyrockets 36% on FDA Approval of Muscular Dystrophy Drug
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sarepta Therapeutics (SRPT) has good news for SRPT stock investors concerning its tr.....»»
First Week of May 2020 Options Trading For Sarepta Therapeutics (SRPT)
Stock Options Channel.....»»
June 15th Options Now Available For Sarepta Therapeutics (SRPT)
Stock Options Channel.....»»
November 2nd Options Now Available For Sarepta Therapeutics (SRPT)
Stock Options Channel.....»»
Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dolla.....»»
April 18th Options Now Available For Sarepta Therapeutics (SRPT)
Stock Options Channel.....»»
June 21st Options Now Available For Sarepta Therapeutics (SRPT)
Stock Options Channel.....»»
Sarepta"s stock is up 11% on positive data from clinical trial for Duchenne treatment
Shares of Sarepta Therapeutics Inc. gained 11.3% in trading on Tuesday after the co.....»»
: Sarepta stock plunges more than 50% after mixed results from drug study
Sarepta Therapeutics Inc. shares lost more than half their value in after-hours trading Thursday, after the company said a drug candidate produced mixed results in a clinical study......»»
In One Chart: Why an IPO ‘meltup’ could signal future trouble for the stock market
A red-hot reception for initial public offerings may offer another sign of froth in a rallying stock market, according to one measure......»»
Do Hedge Funds Love Sarepta Therapeutics Inc (SRPT)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and pr.....»»
Sarepta Therapeutics Enters Oversold Territory (SRPT)
Dividend Channel.....»»
Analysts: Roche Partnership Derisks Sarepta Investor Concerns
Sarepta Therapeutics Inc (NASDAQ: SRPT) has entered a partnership with Roche (OTC: Latest Ratings for SRPT.....»»
Benzinga Pro"s Top 5 Stocks To Watch For Mon., Dec. 23, 2019: SRPT, ROK, CNSL, DPW, XFOR
Benzinga Pro's Stocks To Watch For Monday Sarepta Therapeutics (SRPT) - Shares were up about 9% Monday morning following news of a partnership with Roche (RRHBY) for its investigational read more.....»»
In an about face, FDA approves Sarepta"s 2nd Duchenne drug
The FDA unexpectedly reversed course Thursday, approving the second treatment developed by Sarepta Therapeutics for the rare disease Duchenne muscular dystrophy just a few months after rejecting the drug. Sarepta (Nasdaq: SRPT) announced Thursday even.....»»
Sarepta stock surges more than 20% as FDA finally OKs muscular dystrophy drug
Sarepta Therapeutics Inc. shares surged in the extended session Thursday after the genetic medicine company said the Food and Drug Admin.....»»
Did Hedge Funds Drop The Ball On Sarepta Therapeutics Inc (SRPT) ?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why.....»»
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q3 2019 Results - Earnings Call Transcript.....»»
In One Chart: A surging stock market belies the biggest disagreement between CEOs and consumers about the U.S. economy on record
The stock market is in full flight Thursday, with all three main U.S. benchmarks poised to end at their highest levels ever, but those glorious gains come amid an uneasy gap in what consumers and C-suiters think about future of the U.S. economy......»»